Business • Health Care

BioNtech-Pfizer vaccine stops 89.4 percent of virus transmission

According to an initial study, the vaccine from BioNtech and its US partner Pfizer apparently largely prevents the transmission of the coronavirus. This is the result of a large observational study conducted jointly with the Israeli Ministry of Health. The study found that the vaccine was 89.4 percent effective in preventing Sars-CoV-2 infections.

The study is based on data from 1.1775 million vaccinated Israelis. Vaccinated people are thus not only protected from disease but also appear to have a high probability of no longer infecting other people.

According to the data, the vaccine also has an efficancy of nearly 96 percent after two doses of vaccination. According to the Israeli Ministry of Health, two weeks after the second dose of vaccine, 95.8 percent fewer infections were found in vaccinated people than in unvaccinated people. One week after the second dose, efficacy is 91.9 percent, according to the report.

I like sports and food.
Card reviewed by: @christoph